Comparable stake leader
Wei-Wu He
SEC ownership of CASI Pharmaceuticals, Inc (DE)
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000895051.
Disclosed value leader
—
Comparable rows
0/8
Latest evidence
07 Sep 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Wei-Wu He
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
07 Sep 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000895051
- Issuer location
- Rockville, MD
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CASI Pharmaceuticals, Inc (DE) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Wei-Wu He
Disclosed value leader
—
Comparable rows
0/8
Latest evidence
07 Sep 2022
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
8 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Wei-Wu He's linked filing trail.
Detailed SEC evidence table Showing 1-8 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Wei-Wu He |
3/4/5
Chairman and CEO, Director, 10%+ Owner
|
—
denominator unverified
|
—
688,660 shares
|
— | 13 Jun 2022 |
| Larry Zhang |
3/4/5
President
|
—
denominator unverified
|
—
800,000 shares
|
— | 24 Jul 2021 |
| Franklin Cary Salisbury Jr. |
3/4/5
Director
|
—
denominator unverified
|
—
388,387 shares
|
— | 25 May 2022 |
| Yue Alexander Wu |
3/4/5
Director
|
—
denominator unverified
|
—
388,387 shares
|
— | 25 May 2022 |
| Quan Zhou |
3/4/5
Director
|
—
denominator unverified
|
—
380,645 shares
|
— | 25 May 2022 |
| James Huang |
3/4/5
Director
|
—
denominator unverified
|
—
371,708 shares
|
— | 06 Sep 2022 |
| Rajesh C. Shrotriya MD |
3/4/5
Director
|
—
denominator unverified
|
—
345,806 shares
|
— | 25 May 2022 |
| Alexander A. Zukiwski |
3/4/5
EVP and Chief Medical Officer
|
—
denominator unverified
|
—
3,000 shares
|
— | 07 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 21 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to CASI Pharmaceuticals, Inc (DE). Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Larry Zhang
Net 12M change
$0
Latest report
07 Sep 2022
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Larry Zhang | President | Mixed | 24 Jul 2021 | |||
| Rajesh C. Shrotriya MD | Director | Mixed | 25 May 2022 | |||
| Alexander A. Zukiwski | EVP and Chief Medical Officer | Mixed | 07 Sep 2022 | |||
| Franklin Cary Salisbury Jr. | Director | Mixed | 25 May 2022 | |||
| Yue Alexander Wu | Director | Mixed | 25 May 2022 | |||
| Wei-Wu He | Chairman and CEO, Director, 10%+ Owner | Mixed | 13 Jun 2022 | |||
| James Huang | Director | Mixed | 06 Sep 2022 | |||
| Quan Zhou | Director | Mixed | 25 May 2022 |
Recent insider transactions for CASI Pharmaceuticals, Inc (DE)
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.